Brief: Advaxis Announces FDA Clearance Of Ind For Adxs-504 For Treatment Of Prostate Cancer
07/01/2020 13:07
Jan 7 (Reuters) - Advaxis Inc ADXS.O :
* ADVAXIS ANNOUNCES FDA CLEARANCE OF IND FOR ADXS-504 FOR
TREATMENT OF PROSTATE CANCER
Source text for Eikon: ID:nGNXDwzqY
Further company coverage: ADXS.O
((Briefs@thomsonreuters.com;))
Recent news on Ayala Pharmaceuticals
See all newsBrief: Ayala Pharmaceuticals Completes Sale Of AL102 To Immunome
Immunome slides on $200 mln equity offering
Immunome edges up after $200 mln equity offering
Brief: Immunome To Acquire AL102 Phase 3 Asset for the Treatment of Desmoid Tumors From Ayala Pharmaceuticals
Brief: Ayala Pharmaceuticals Announces AL102 Receives Orphan Drug Designation for Desmoid Tumors